Literature DB >> 6866327

Choline acetyltransferase immunohistochemistry in brains of Alzheimer's disease patients and controls.

T Nagai, P L McGeer, J H Peng, E G McGeer, C E Dolman.   

Abstract

Choline acetyltransferase (ChAT)-containing neuronal structures of the basal forebrain were studied by ChAT immunohistochemistry in the brains of persons dying with Alzheimer's disease (SDAT), as well as age-matched controls dying without neurological disorder. A loss of greater than 50% in ChAT-containing neurons was found in the substantia innominata in the SDAT group. In contrast, there was no reduction in the number of ChAT-containing neurons of the putamen as compared with controls. The data confirm the reason for the reduction of ChAT as measured biochemically in the neocortex of SDAT cases, and support the cholinergic hypothesis of memory.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6866327     DOI: 10.1016/0304-3940(83)90264-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  17 in total

1.  MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia.

Authors:  Haruo Hanyu; Tetsuichi Asano; Hirofumi Sakurai; Yuriko Tanaka; Masaru Takasaki; Kimihiko Abe
Journal:  AJNR Am J Neuroradiol       Date:  2002-01       Impact factor: 3.825

2.  Selective neurodegeneration, without neurofibrillary tangles, in a mouse model of Niemann-Pick C disease.

Authors:  D C German; E M Quintero; C L Liang; B Ng; S Punia; C Xie; J M Dietschy
Journal:  J Comp Neurol       Date:  2001-05-07       Impact factor: 3.215

3.  The nucleus basalis of Meynert in multi-infarct (vascular) dementia.

Authors:  D M Mann; P O Yates; B Marcyniuk
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

4.  Nucleus basalis lesions in neonate rats induce a selective cortical cholinergic hypofunction and cognitive deficits during adulthood.

Authors:  G J Sengstock; K B Johnson; P T Jantzen; E M Meyer; A J Dunn; G W Arendash
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

5.  Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer's disease.

Authors:  Michel Grothe; Laszlo Zaborszky; Mercedes Atienza; Eulogio Gil-Neciga; Rafael Rodriguez-Romero; Stefan J Teipel; Katrin Amunts; Aida Suarez-Gonzalez; Jose L Cantero
Journal:  Cereb Cortex       Date:  2009-11-04       Impact factor: 5.357

6.  Dopaminergic neurotransmitter systems in Alzheimer's disease and in Down's syndrome at middle age.

Authors:  D M Mann; P O Yates; B Marcyniuk
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-03       Impact factor: 10.154

7.  The differential involvement of subcortical nuclei in senile dementia of Alzheimer's type.

Authors:  G K Wilcock; M M Esiri; D M Bowen; A O Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

8.  Volume Loss of the Nucleus Basalis of Meynert is Associated with Atrophy of Innervated Regions in Mild Cognitive Impairment.

Authors:  Jose L Cantero; Laszlo Zaborszky; Mercedes Atienza
Journal:  Cereb Cortex       Date:  2017-08-01       Impact factor: 5.357

9.  Selective loss of cholinergic neurons in the ventral striatum of patients with Alzheimer disease.

Authors:  S Lehéricy; E C Hirsch; P Cervera; L B Hersh; J J Hauw; M Ruberg; Y Agid
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

10.  Neurone loss in the nucleus basalis of Meynert in Creutzfeldt-Jakob disease.

Authors:  T Arendt; V Bigl; A Arendt
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.